GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE1757.45-24.25 (-1.36 %)
PREV CLOSE ( ) 1781.70
OPEN PRICE ( ) 1780.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1992
TODAY'S LOW / HIGH ( )1751.15 1792.15
52 WK LOW / HIGH ( )861.5 2195.75
NSE1756.70-25.2 (-1.41 %)
PREV CLOSE( ) 1781.90
OPEN PRICE ( ) 1797.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1756.70 (9)
VOLUME 89617
TODAY'S LOW / HIGH( ) 1747.30 1797.00
52 WK LOW / HIGH ( )861 2194
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020
Profit Before Tax10545.8216185.5213348.109928.66
Adjustment381.92-282.66173.03321.48
Changes In working Capital-4179.41-3930.08-4357.59-799.42
Cash Flow after changes in Working Capital6748.3311972.789163.549450.72
Cash Flow from Operating Activities3639.687907.696049.297009.35
Cash Flow from Investing Activities12081.88-10026.21-15240.00-7660.78
Cash Flow from Financing Activities149.19348.9812384.60-68.71
Net Cash Inflow / Outflow15870.75-1769.543193.89-720.14
Opening Cash & Cash Equivalents3188.204924.631694.972364.02
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANA
Effect of Foreign Exchange Fluctuations30.0033.1135.7751.09
Closing Cash & Cash Equivalent19088.953188.204924.631694.97

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.